Procalcitonin As A Diagnostic And Prognostic Marker In Community Acquired Pneumonia

被引:0
|
作者
Bappanad, D. [1 ]
Moser, B. [2 ]
Woods, C. [1 ]
Cairns, C. B. [3 ]
Kraft, M. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5972
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia
    Julian-Jimenez, Agustin
    Timon-Zapata, Jesus
    Laserna-Mendieta, Emilio Jose
    Parejo-Miguez, Raquel
    Flores-Chacartegui, Manuel
    Gallardo-Schall, Pablo
    MEDICINA CLINICA, 2014, 142 (07): : 285 - 292
  • [42] Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults
    Martinot, M
    Hansmann, Y
    De Martino, S
    Lesens, O
    Coumaros, G
    Pencreach, E
    Bertrand, M
    Christmann, D
    PRESSE MEDICALE, 2001, 30 (22): : 1091 - 1096
  • [43] Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia
    Boussekey, N
    Leroy, O
    Alfandari, S
    Devos, P
    Georges, H
    Guery, B
    INTENSIVE CARE MEDICINE, 2006, 32 (03) : 469 - 472
  • [44] Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia
    Nicolas Boussekey
    Olivier Leroy
    Serge Alfandari
    Patrick Devos
    Hugues Georges
    Benoit Guery
    Intensive Care Medicine, 2006, 32 : 469 - 472
  • [45] The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
    Nikzad M.
    Banafshe H.R.
    Momen-Heravi M.
    Haddad Kashani H.
    Shiehmorteza M.
    Clinical and Molecular Allergy, 19 (1)
  • [46] Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study
    W. H. Cho
    H. J. Yeo
    S. H. Yoon
    S. E. Lee
    D. S. Jeon
    Y. S. Kim
    S. J. Lee
    E. J. Jo
    J. H. Mok
    M. H. Kim
    K. U. Kim
    K. Lee
    H. K. Park
    M. K. Lee
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 309 - 315
  • [47] Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia
    Lee, Jae Hyuk
    Chung, Hea Jin
    Kim, Kyuseok
    Jo, You Hwan
    Rhee, Joong Eui
    Kim, Yu Jin
    Kang, Kyeong Won
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (01): : 72 - 79
  • [48] Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study
    Cho, W. H.
    Yeo, H. J.
    Yoon, S. H.
    Lee, S. E.
    Jeon, D. S.
    Kim, Y. S.
    Lee, S. J.
    Jo, E. J.
    Mok, J. H.
    Kim, M. H.
    Kim, K. U.
    Lee, K.
    Park, H. K.
    Lee, M. K.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (02) : 309 - 315
  • [49] Procalcitonin used as an early diagnostic and prognostic marker in septic shock
    Clec'h, C
    Ferrière, F
    Karoubi, P
    Fosse, J
    Hoang, P
    Tuil, O
    Cohen, Y
    INTENSIVE CARE MEDICINE, 2002, 28 : S173 - S173
  • [50] Community-Acquired Pneumonia Diagnostic vs Prognostic Significance of the Platelet Count Response
    Georges, Hugues
    Brogly, Nicolas
    Alfandari, Serge
    Leroy, Olivier
    CHEST, 2011, 139 (05) : 1256 - 1257